VIDEO | AUSBIZ Amplia's $12M plan; what's next for the Aussie medtech

 

Amplia CEO, Dr John Lambert  spoke with Annette Beacher and David Scutt from Ausbiz this week about the Company's $12.4 million capital raising announcement, and plans to progress AMP945 to Phase 2 clinical trials in pancreatic cancer patients in 2022.